These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1161972

  • 1. Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.
    Sabelli HC, Vazquez AJ, Flavin D.
    Psychopharmacologia; 1975 May 28; 42(2):117-25. PubMed ID: 1161972
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Behavioral effects of β-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms.
    Mosnaim AD, Hudzik T, Wolf ME.
    Am J Ther; 2015 May 28; 22(6):412-22. PubMed ID: 26544964
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characteristics of antinociception induced by noncatecholic phenylethylamine derivatives: the relation of endogenous norepinephrine to phenylethylamine analog-induced antinociception.
    Matsuoka Y, Sakuma M, Sugioka T, Terawaki Y, Uruno T, Kubota K.
    Jpn J Pharmacol; 1988 Oct 28; 48(2):263-72. PubMed ID: 3210449
    [Abstract] [Full Text] [Related]

  • 9. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC, Pedemonte WA, Whalley C, Mosnaim AD, Vazquez AJ.
    Life Sci; 1974 Jan 01; 14(1):149-56. PubMed ID: 4810493
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The enigma of conditioned taste aversion learning: stimulus properties of 2-phenylethylamine derivatives.
    Greenshaw AJ, Turrkish S, Davis BA.
    Physiol Res; 2002 Jan 01; 51 Suppl 1():S13-20. PubMed ID: 12479782
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
    Dourish CT.
    Br J Pharmacol; 1982 Sep 01; 77(1):129-39. PubMed ID: 6982090
    [Abstract] [Full Text] [Related]

  • 17. Some further observations of the effect of beta-phenethylamine on locomotor activity in mice.
    Jackson DM.
    J Pharm Pharmacol; 1975 Apr 01; 27(4):278-80. PubMed ID: 239123
    [No Abstract] [Full Text] [Related]

  • 18. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC, Giardina WJ, Myles SB, Vazquez AJ.
    Arzneimittelforschung; 1974 Mar 01; 24(3):333-7. PubMed ID: 4407412
    [No Abstract] [Full Text] [Related]

  • 19. 2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.
    Paetsch PR, Greenshaw AJ.
    Neurochem Res; 1993 Sep 01; 18(9):1015-22. PubMed ID: 7901780
    [Abstract] [Full Text] [Related]

  • 20. Action of beta-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission.
    Barroso N, Rodriguez M.
    Eur J Pharmacol; 1996 Feb 22; 297(3):195-203. PubMed ID: 8666050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.